A phase I/IIa, double-blind, randomized, placebo-controlled study of antiviral agent in patients with chronic hepatitis B infection to investigate the safety, pharmacokinetics and antiviral activity of ascending 4-week oral doses of LB80380
Grant Data
Project Title
A phase I/IIa, double-blind, randomized, placebo-controlled study of antiviral agent in patients with chronic hepatitis B infection to investigate the safety, pharmacokinetics and antiviral activity of ascending 4-week oral doses of LB80380
Principal Investigator
Professor Yuen, Richard Man Fung
(Principal Investigator)
Duration
24
Start Date
2004-04-01
Amount
430000
Conference Title
A phase I/IIa, double-blind, randomized, placebo-controlled study of antiviral agent in patients with chronic hepatitis B infection to investigate the safety, pharmacokinetics and antiviral activity of ascending 4-week oral doses of LB80380
Presentation Title
Keywords
Chronic Hepatitis B
Discipline
Gastroenterology/Hepatobiliary
HKU Project Code
N/A
Grant Type
LG Life Sciences, Ltd. - General Award
Funding Year
2003
Status
Completed